MedPath

The effect of melatonin in patients with diabetic nephropathy

Phase 3
Recruiting
Conditions
diabetic nephropathy.
Glomerular disorders in diabetes mellitus (E10-E14 with common fourth character .2†)
N08.3*
Registration Number
IRCT20150606022562N5
Lead Sponsor
Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

GFR 15 to 89 ml per minute
Moderate blood pressure (systolic pressure 140-160 and diastolic pressure 80-100 mmHg)
No specific cardiovascular disease, cancer, inflammatory diseases, autoimmune and hyper or hypothyroidism
Non-presence of urinary tract infection and other factors of proteinuria

Exclusion Criteria

Special illness that leads to hospitalization.
High blood pressure (systolic pressure upper than 160 and diastolic pressure upper than 100 mmHg)
Unwillingness to cooperate
Taking fluvoxamine and any antioxidant supplement
Working at night shifts
Smoking and alcohol consumption
Breastfeeding and pregnancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insulin. Timepoint: At the beginning of the study and 12 weeks after intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and 12 weeks after intervention. Method of measurement: HOMA formula.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath